Seeing her husband getting in shape for a charity race made Tonya Walker long for the days – before Parkinson’s – when running was a part of her life. Here, the fashion blogger tells how she swapped her trademark high heels for trainers and fought to regain her fitness for her first long-distance charity race since being diagnosed
On January 6th, I completed the Walt Disney World Marathon Weekend 10km race. This is the longest distance I have run since my Parkinson’s diagnosis. As I write this, I’m still in disbelief that I actually completed a 10k and survived (well, for the most part). The post-race week was a little rough getting my meds back on schedule and regaining a normal sleep pattern – at least as normal as it can get for a Parkie. It was worth it all – here’s why.
It was one year ago when we met a fantastic group of Team Fox athletes participating in the Disney Marathon weekend. My husband, who was not a runner at the time, became one of those runners. He successfully completed the 10k – his first race ever. I was so proud of him. As he trained for the race, I longed for the days when running was a regular part of my life, before Parkinson’s. I was a little envious that he could run, but I couldn’t. At least I thought I couldn’t.
On that weekend a year ago, I watched as several runners with Parkinson’s complete races ranging from the 10k to the Dopey Challenge (Day 1: 5k; Day 2: 10k; Day 3: half marathon; Day 4: marathon). I thought why not me too? I committed to running the 10k in 2017. I felt confident that having one year to prepare would be sufficient.
Over the last year I intermittently trained for the race. I kept procrastinating. It was too hot. I was too tired. Needless to say, I did not feel prepared to run a 10k, but I had made a commitment and so many people were supporting me emotionally and financially (through their generous Team Fox donations). I did not want to let them down.
On race day, I woke up at 1:30am to prepare for the 5:30am race. I had to give my body time to wake up, my meds to be properly timed, and my mind to prepare. Two hours later I was on the Disney bus being transported to the start line. Smiling on the outside, but inside wondering if I could really do this. My amazing husband had a plan for us to succeed – a run/walk regimen. He is my rock and my strength. He knows when I’m capable of pushing my limits and when it’s time to take a moment of rest.
Tonya Walker at the start line at 5:30am
Shortly after we got to the start line area, we met up with the other Team Fox runners. They are seasoned runners and they were SUPER excited to be there. Their enthusiasm was contagious. We laughed, goofed around and took pictures as we waited for the race to begin. Most of these people I had met over the last year, either in person or on social media. We all know each other, but bonded even more over the weekend. We all share a common goal – to outrun Parkinson’s.
This year there were 90 Team Fox runners/walkers who participated in races ranging from the 5k to the Dopey Challenge. Eight members of the group have Parkinson’s.
Tonya and family cheering the runners on over the Walt Disney Weekend marathon course
When we finished the race, I felt like I could keep running for another few miles! I was so excited that I immediately committed to the half marathon for 2018. I even got a little “dopey” and considered doing the Dopey Challenge but I think I’ll stick with the half marathon, unless my Team Fox family convinces me otherwise.
Overall, it was a fantastic family weekend. My son and parents joined in the fun by cheering us on. We stayed the weekend to cheer on the marathoners too!
Tonya and husband Chad at the end of the 10km race
‘The Shoe Maven’
Tonya Walker has been living with Parkinson’s disease since the age of 32 and had DBS surgery on her left side in 2013 and then on her right in 2015. She created ‘The Shoe Maven’ fashion blog in 2015, started up her own fashion label called TSM Originals in aid of The Michael J Fox Foundation. Tonya is a passionate advocate for increased awareness of young-onset Parkinson’s and loves shoes. She lives in Florida, US, with her husband and young son, where she is also a law professor.
Researchers carry out ‘world-first’ stem cell treatment for Parkinson’s disease
Revolutionary stem cells injected into brain of Parkinson’s patient
5 months ago
35 new Parkinson’s drug trials launched in last year
Researchers launched 35 new clinical trials of Parkinson’s drug therapies in the last year, according to recent findings published in the ‘Journal of Parkinson’s Disease’. The 2023 Parkinson’s drug development pipeline report noted a slight decrease in active trials compared to the 2022 update (down from 147 to 139 overall). About one-third of trials were still in Phase 1, half were in Phase 2 – and just 20 (14%) were in Phase 3, raising concerns about ‘slow progress’. However, of the active trials logged on ClinicalTrials.gov at the time of the latest report, 35 were found to be newly registered. The report authors concluded: “The slow progress and lack of agents transitioning from Phase 2 to Phase 3 is concerning, but collective efforts by various stakeholders are being made to accelerate the clinical trial process, with the aim of bringing new therapies to the [Parkinson’s] community sooner.”
Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award
Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…
Study explores predictors of cognitive impairment in Parkinson’s disease
Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.